Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anluo Huaxian Pills (Inner Mongolia Furui Medical Science Co., Ltd.)
- Development stage
- Unknown
- Lead developer
- Senlong Pharmaceutical
- Administration
- Oral
01
Overview
Anluo Huaxian Pills (Anluo Huaxian Wan) is a Traditional Chinese Medicine (TCM) formulation approved in China for the treatment of chronic hepatitis B and liver fibrosis. Developed and manufactured by Inner Mongolia Furui Medical Science, the pills are composed of several herbal components, including *Radix Astragali*, *Radix Salviae Miltiorrhizae*, *Carapax Trionycis*, and *Radix Notoginseng*. The drug exerts its therapeutic effects through multi-target mechanisms, primarily by inhibiting the activation of hepatic stellate cells (HSCs), downregulating the expression of transforming growth factor-beta 1 (TGF-β1), and promoting the degradation of the extracellular matrix (ECM). Clinical studies have demonstrated its efficacy in improving liver function, reducing liver stiffness, and potentially reversing early-stage liver fibrosis when used alone or in combination with nucleos(t)ide analogues or other TCM regimens.
- Brand names
- Anluo Huaxian Pills
- Other names
- Anluo Huaxian Wan
02
Targets
TGFB1 (Transforming growth factor Beta-1 proprotein)
Beyond the preview
Go deeper on Anluo Huaxian Pills (Inner Mongolia Furui Medical Science Co., Ltd.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anluo Huaxian Pills (Inner Mongolia Furui Medical Science Co., Ltd.).